Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1097/PPO.0000000000000103 http://scihub22266oqcxt.onion/10.1097/PPO.0000000000000103 C5588661!5588661!25815846     free     free     free Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Cancer+J 2015 ; 21 (2): 70-4 Nephropedia Template TP {{tp|p=25815846|t=2015. Metformin, an Old Drug, Brings a New Era to Cancer Therapy |pdf=|usr=}}{{25815846}} gab.com Text Metformin, an Old Drug, Brings a New Era to Cancer Therapy JO: Cancer J http://www.kidney.de/pget.php?&tw=1&pmid=25815846 #FOAvip Metformin is the most commonly prescribed drug for type 2 diabetes mellitus as it is inexpensive, safe, and efficient in ameliorating hyperglycemia and hyperinsulinemia. Epidemiological and clinical observation studies have shown that metformin use reduces risk of cancer in patients with type 2 diabetes mellitus and improves prognosis and survival rate of the cancer patients. Furthermore, ongoing clinical trials of metformin in cancer therapy are extending to nondiabetic population. Thus, metformin is emerging as an attractive candidate for cancer prevention and treatment. This review summarizes recent progress in studies of metformin use in cancer and discusses the possibility to enhance its efficacy and to prevent cancer metastasis. Twit Text FOAVip Metformin, an Old Drug, Brings a New Era to Cancer Therapy ????Cancer J http://www.kidney.de/pget.php?&tw=1&pmid=25815846 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=25815846 #FOAvip English Wikipedia <ref>{{Cite pmid|25815846}}</ref> Metformin, an Old Drug, Brings a New Era to Cancer Therapy #MMPMID25815846 He H; Ke R; Lin H; Ying Y; Liu D; Luo Z Cancer J 2015[Mar]; 21 (2): 70-4 PMID25815846show ga Metformin is the most commonly prescribed drug for type 2 diabetes mellitus as it is inexpensive, safe, and efficient in ameliorating hyperglycemia and hyperinsulinemia. Epidemiological and clinical observation studies have shown that metformin use reduces risk of cancer in patients with type 2 diabetes mellitus and improves prognosis and survival rate of the cancer patients. Furthermore, ongoing clinical trials of metformin in cancer therapy are extending to nondiabetic population. Thus, metformin is emerging as an attractive candidate for cancer prevention and treatment. This review summarizes recent progress in studies of metformin use in cancer and discusses the possibility to enhance its efficacy and to prevent cancer metastasis. äMetformin, an Old Drug, Brings a New Era to Cancer Therapy (epmc).pdf DeepDyve Pubget Overpricing